Author: Meng, Fandan; Ren, Yudong; Suo, Siqingaowa; Sun, Xuejiao; Li, Xunliang; Li, Pengchong; Yang, Wei; Li, Guangxing; Li, Lu; Schwegmann-Wessels, Christel; Herrler, Georg; Ren, Xiaofeng
Title: Evaluation on the Efficacy and Immunogenicity of Recombinant DNA Plasmids Expressing Spike Genes from Porcine Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus Document date: 2013_3_19
ID: 081o2zmd_47
Snippet: In summary, to the best of our knowledge, this is the first time that the immunological efficacies triggered by PEDV S protein and the TGEV S protein were compared using a mouse model. Both the recombinant plasmids pIRES-(TGEV-S1-PEDV-S1) and pIRES-(TGEV-S1-PEDV-S) could elicit in mice cellular immunity, T-cell response as well as humoral response generating CTLs, helper T cells, particularly of Th1 cells, as well as specific neutralizing antibod.....
Document: In summary, to the best of our knowledge, this is the first time that the immunological efficacies triggered by PEDV S protein and the TGEV S protein were compared using a mouse model. Both the recombinant plasmids pIRES-(TGEV-S1-PEDV-S1) and pIRES-(TGEV-S1-PEDV-S) could elicit in mice cellular immunity, T-cell response as well as humoral response generating CTLs, helper T cells, particularly of Th1 cells, as well as specific neutralizing antibodies against PEDV and TGEV, respectively. It has been reported that an antigenic domain in the S gene that could elicit a strong antibody response and induce neutralizing antibodies has excellent immunogenicity on the C-terminal portion of the S protein [5] . Our results confirmed that the fulllength PEDV S gene induces a better immune response than the N-terminal half alone.
Search related documents:
Co phrase search for related documents- antibody response and excellent immunogenicity: 1, 2
- antibody response and humoral response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody response and humoral response generate: 1
- antibody response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody response and immunological efficacy: 1, 2, 3, 4
- antibody response and mice cellular immunity: 1, 2, 3, 4, 5
- antibody response and mouse model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody response and neutralize antibody: 1, 2, 3, 4, 5, 6, 7, 8
- antigenic domain and excellent immunogenicity: 1
- antigenic domain and humoral response: 1, 2, 3
- antigenic domain and immune response: 1, 2, 3
- cellular immunity and humoral response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cellular immunity and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cellular immunity and immunological efficacy: 1
- cellular immunity and mice cellular immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cellular immunity and mouse model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- excellent immunogenicity and neutralize antibody: 1
- humoral response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- humoral response and immunological efficacy: 1, 2
Co phrase search for related documents, hyperlinks ordered by date